AIDS Vaccines
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects (NCT01610427) | GlaxoSmithKline | 2012-06-25 |
| Phase 1 Safety Study of Two Experimental HIV Vaccines (NCT00479999) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-05-24 |
Track AIDS Vaccines automatically
Every clearance here is in the API, with alerts when new ones post.